SLNO – soleno therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

SLNO

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/4

05:23 pm

slno

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses

Low Report

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses

Report

12/3

04:17 pm

slno

Soleno Therapeutics Announces the Passing of Board Member William G. Harris [Yahoo! Finance]

Medium Report

Soleno Therapeutics Announces the Passing of Board Member William G. Harris [Yahoo! Finance]

Report

12/3

04:05 pm

slno

Soleno Therapeutics Announces the Passing of Board Member William G. Harris

Medium Report

Soleno Therapeutics Announces the Passing of Board Member William G. Harris

Report

12/1

05:48 pm

slno

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses

Low Report

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses

Report

11/30

09:33 pm

slno

Soleno Therapeutics (SLNO): Does Current Valuation Signal Opportunity or Caution for Investors? [Yahoo! Finance]

Low Report

Soleno Therapeutics (SLNO): Does Current Valuation Signal Opportunity or Caution for Investors? [Yahoo! Finance]

Report

11/25

08:51 am

slno

Soleno Therapeutics (SLNO) Reports Strong Q3 Earnings Despite VYKAT XR Safety Concerns [Yahoo! Finance]

Low Report

Soleno Therapeutics (SLNO) Reports Strong Q3 Earnings Despite VYKAT XR Safety Concerns [Yahoo! Finance]

Report

11/24

12:03 pm

slno

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses

Low Report

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses

Report

11/24

08:00 am

slno

Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference

Low Report

Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference

Report

Date

Time

Symbol

Company Name

Action

%Chg

11/4/2025

04:01 pm

SLNO

soleno therapeutics, inc.

BEAT Report

-26.4%

soleno therapeutics, inc.

Report

8/6/2025

04:01 pm

SLNO

soleno therapeutics, inc.

BEAT Report

-3.1%

soleno therapeutics, inc.

Report

5/7/2025

04:01 pm

SLNO

soleno therapeutics, inc.

BEAT Report

2.1%

soleno therapeutics, inc.

Report

Date

Time

Action

From

Firm

Impact

%Chg

11/20

06:03 am

Upgrades

Strong-Buy

Wolfe Research

Medium

Report

-6.3%

Report

11/20

06:03 am

Upgrades

Strong-Buy

Wolfe Research

Medium

Report

-6.3%

Report

11/18

11:44 am

Initiates

Outperform

Wolfe Research

Low

Report

1.3%

Report

11/18

11:44 am

Initiates

Outperform

Wolfe Research

Low

Report

1.3%

Report

11/18

09:00 am

Initiates

Outperform

Wolfe Research

Medium

Report

3.2%

Report

11/18

09:00 am

Initiates

Outperform

Wolfe Research

Medium

Report

3.2%

Report

11/17

04:17 pm

Initiates

OUTPERFORM

WOLFE RESEARCH

Low

Report

2.7%

Report

11/17

04:17 pm

Initiates

OUTPERFORM

WOLFE RESEARCH

Low

Report

2.7%

Report

Date

Time

Symbol

Headline

Impact

11/19

06:50 pm

slno

Form 4 SOLENO THERAPEUTICS INC For: Nov 17 Filed by: Norrett Kevin

Medium Report

Form 4 SOLENO THERAPEUTICS INC For: Nov 17 Filed by: Norrett Kevin

Report

11/19

06:49 pm

slno

Form 3 SOLENO THERAPEUTICS INC For: Nov 17 Filed by: Norrett Kevin

Medium Report

Form 3 SOLENO THERAPEUTICS INC For: Nov 17 Filed by: Norrett Kevin

Report

11/14

06:35 pm

slno

Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: Vivo Opportunity Fund Holdings, L.P.

Medium Report

Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: Vivo Opportunity Fund Holdings, L.P.

Report

11/14

11:58 am

slno

Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: JANUS HENDERSON GROUP PLC

Low Report

Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: JANUS HENDERSON GROUP PLC

Report

11/13

09:09 am

slno

Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: Adage Capital Management, L.P.

Low Report

Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: Adage Capital Management, L.P.

Report

11/12

05:21 pm

slno

Form 4 SOLENO THERAPEUTICS INC For: Nov 10 Filed by: Joshi Manher

Low Report

Form 4 SOLENO THERAPEUTICS INC For: Nov 10 Filed by: Joshi Manher

Report

11/12

05:19 pm

slno

Form 3 SOLENO THERAPEUTICS INC For: Nov 10 Filed by: Joshi Manher

Low Report

Form 3 SOLENO THERAPEUTICS INC For: Nov 10 Filed by: Joshi Manher

Report

11/12

06:10 am

slno

Form 8-K SOLENO THERAPEUTICS INC For: Nov 10

Medium Report

Form 8-K SOLENO THERAPEUTICS INC For: Nov 10

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.